MedTrace Logo

A Study of TRV130 for the Treatment of Pain After Abdominoplasty

NCT02335294 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2020-09-16

Study results available
· View outcomes & findings →

Summary

The primary objective is to evaluate the analgesic efficacy of IV TRV130 compared with placebo in patients with acute postoperative pain following abdominoplasty.

Conditions

Interventions

DRUG

TRV130

Rescue: Ibuprofen, oxycodone

DRUG

Morphine

Rescue: Ibuprofen, oxycodone

DRUG

Placebo

Rescue: Ibuprofen, oxycodone

Sponsors & Collaborators

  • Lotus Clinical Research, LLC

    collaborator OTHER

  • Trevena Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2015-07-31
Completion
2015-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02335294 on ClinicalTrials.gov